Lung Cancer Screening Rates Remain Low
Only about 18% of eligible US adults underwent lung cancer screening in 2022, lagging far behind rates for breast and colorectal cancer screenings.
Category: Products & Treatment
Products & Treatment
Latest
Products & Treatment
Latest
Federal Grant to Fund Inhaled Vaccines
A $20.7M federal grant will fund a 5-year inhaled vaccines initiative at the Icahn School of Medicine at Mount Sinai beginning with development of an avian influenza nasal spray prototype.
Products & Treatment
Latest
Capnography and Pulse Oximetry in the PICU
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
Industry & Regulatory News
Latest
Siemens Healthineers Receives ASTRO Award
The inaugural honor from the American Society for Radiation Oncology (ASTRO) recognizes longstanding contributions to cancer care technology, education, and clinical research.
Pharmaceuticals
Latest
FDA Grants Priority Review for Arikayce Inhaled Antibiotic for MAC
The FDA accepted Insmed's supplemental new drug application with Priority Review for Arikayce to treat Mycobacterium avium complex (MAC) lung disease.
Diagnostics & Testing
Latest
Sepsis ImmunoScore Diagnostic Added at Sinai Hospital
The Sepsis ImmunoScore is the first sepsis artificial intelligence diagnostic tool authorized by the FDA and uses patient data to assess risk within 24 hours.
Monitoring & Treatment
Latest
Laughter Therapy Comparable to Breathing Exercises for COPD Patients
Deliberate laughter therapy exercises are as effective as traditional breathing techniques for improving symptoms and overall health.